At nine and twelve months the distribution continued to shift modestly, with 33% still showing further improvement, and 20% and 21% worse than their pre-GLP-1 level, respectively
GLP-1 Agonists and Pancreatitis Risk: Reassessing an Old Concern with New Evidence A Renewed Look at an Old Controversy Ever since GLP-1 receptor agonists (GLP-1 RAs) entered clinical practice for diabetes and obesity, their metabolic benefits have been undeniable
The same case report documented biological age reduction and telomere length increase, with the patient's biological age decreasing by 7.9 years (from 75.93 to 68.03) and telomere length increasing from 6.45 to 6.59 kb over one year of treatment
I felt terrible, and for a few days after my balance, speach and memory were all affected
I personally use Join Josie ( for compounded tirzepatide, even though my BMI is only 20